Skip to main content

Radiopharm Theranostics Ltd

RADX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001949257

No open-market purchases or sales by Radiopharm Theranostics Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $1.18M in total; no superinvestor holds it.

Other share classesRDPTF

Q2 2026 vs. Q1 2026

How the institutions holding Radiopharm Theranostics Ltd changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of RADX: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders76−1
Shares51.3M51.1M−184.0K (−0.4%)
Value$2.06M$1.18M−$880.8K (−42.7%)

New holders (0)

Institutions that held Radiopharm Theranostics Ltd at the end of Q2 2026 but not at the end of Q1 2026.

None.

Sold out (1)

Institutions that held Radiopharm Theranostics Ltd at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of RADX in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Silverarc Capital Management, LLC187,406$805.8K